PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials.
Journal: Frontiers in oncology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Lv S, Ma C, Tang Z, et al. (2026). "PD-1/PD-L1 inhibitors in the treatment of pMMR mCRC: a meta-analysis based on randomized controlled trials.". Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1969514